GI DYNAMICS, INC.

Other languages GI Dynamics, Inc.

Equities

GIDYL

AU000000GID7

Delayed OTC Markets Other stock markets			5-day change	1st Jan Change
- ^USD	-.--%		-.--%	-99.33%

06-04	Morphic Medical Inc. Receives Approval from the U.S. Food and Drug Administration for Amendments to Certain Requirements for Its Pivotal Study	CI
2023	GI Dynamics, Inc. Announces First Patient Enrolled in the I-STEP Clinical Study of EndoBarrier in India	CI

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Morphic Medical Inc. Receives Approval from the U.S. Food and Drug Administration for Amendments to Certain Requirements for Its Pivotal Study	06-04
GI Dynamics, Inc. Announces First Patient Enrolled in the I-STEP Clinical Study of EndoBarrier in India	13/02/23
GI Dynamics, Inc. Announces Final Data from the ENDO Trial, Multicenter Study Demonstrating the Potential Use of EndoBarrier to Treat Type II Diabetes and Obesity	15/06/22
GI Dynamics Inc. Announces Approval of the I-STEP Clinical Study in India	31/01/22
Gi Dynamics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	07/05/21
Gi Dynamics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	12/03/21
Gi Dynamics, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020	10/11/20
Gi Dynamics, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020	07/08/20

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer